Shuyang Zhang to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Shuyang Zhang has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.044
-
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. Clin Immunol. 2020 05; 214:108393.
Score: 0.044